Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Helminth-Based Product and the Microbiome of Mice with Lupus.

Neuman H, Mor H, Bashi T, Givol O, Watad A, Shemer A, Volkov A, Barshack I, Fridkin M, Blank M, Shoenfeld Y, Koren O.

mSystems. 2019 Feb 19;4(1). pii: e00160-18. doi: 10.1128/mSystems.00160-18. eCollection 2019 Jan-Feb.


Helminths-based bi-functional molecule, tuftsin-phosphorylcholine (TPC), ameliorates an established murine arthritis.

Blank M, Bashi T, Lachnish J, Ben-Ami-Shor D, Shovman O, Fridkin M, Eisenstein M, Volkov A, Barshack I, Shoenfeld Y.

PLoS One. 2018 Aug 8;13(8):e0200615. doi: 10.1371/journal.pone.0200615. eCollection 2018.


Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.

Shemer A, Kivity S, Shovman O, Bashi T, Perry O, Watad A, Ben-Ami Shor D, Volkov A, Barshack I, Bragazzi NL, Krule A, Fridkin M, Amital H, Blank M, Shoenfeld Y.

Clin Exp Immunol. 2018 Aug;193(2):160-166. doi: 10.1111/cei.13137.


Tuftsin-Phosphorylcholine Maintains Normal Gut Microbiota in Collagen Induced Arthritic Mice.

Ben-Amram H, Bashi T, Werbner N, Neuman H, Fridkin M, Blank M, Shoenfeld Y, Koren O.

Front Microbiol. 2017 Jul 10;8:1222. doi: 10.3389/fmicb.2017.01222. eCollection 2017.


Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis.

Bashi T, Shovman O, Fridkin M, Volkov A, Barshack I, Blank M, Shoenfeld Y.

Clin Exp Immunol. 2016 Apr;184(1):19-28. doi: 10.1111/cei.12745. Epub 2016 Feb 4.


Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications.

Versini M, Jeandel PY, Bashi T, Bizzaro G, Blank M, Shoenfeld Y.

BMC Med. 2015 Apr 13;13:81. doi: 10.1186/s12916-015-0306-7. Review.


Successful modulation of murine lupus nephritis with tuftsin-phosphorylcholine.

Bashi T, Blank M, Ben-Ami Shor D, Fridkin M, Versini M, Gendelman O, Volkov A, Barshak I, Shoenfeld Y.

J Autoimmun. 2015 May;59:1-7. doi: 10.1016/j.jaut.2015.03.001. Epub 2015 Apr 10.


Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease.

Ben-Ami Shor D, Bashi T, Lachnish J, Fridkin M, Bizzaro G, Barshak I, Blank M, Shoenfeld Y.

J Autoimmun. 2015 Jan;56:111-7. doi: 10.1016/j.jaut.2014.11.001. Epub 2014 Dec 3.


The mechanisms behind helminth's immunomodulation in autoimmunity.

Bashi T, Bizzaro G, Ben-Ami Shor D, Blank M, Shoenfeld Y.

Autoimmun Rev. 2015 Feb;14(2):98-104. doi: 10.1016/j.autrev.2014.10.004. Epub 2014 Oct 16. Review.


Treating inflammatory bowel disease: from helminths to ova.

Bashi T, Blank M, Shoenfeld Y.

Isr Med Assoc J. 2014 Oct;16(10):627-8. No abstract available.


Idiotype-specific intravenous immunoglobulin (IVIG) for therapy of autoimmune diseases.

Blank M, Bashi T, Shoenfeld Y.

Methods Mol Biol. 2014;1060:353-61. doi: 10.1007/978-1-62703-586-6_18.


Supplemental Content

Support Center